This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
Mark Your Calendar for BPI US West 2024!
March 11-14, 2024Town and Country Resort, San Diego

Shawn Allwein
Vice President, Biologics CMC at Teva


Shawn earned his PhD from the University of Arizona in Synthetic Organic Chemistry which was followed by an NIH Postdoctoral Fellowship at the University of North Carolina, Chapel Hill. His initial entry into the pharmaceutical industry was within Merck’s small molecule Process Research group before moving to Cephalon and then Teva Pharmaceuticals. Prior to shifting to biologics, Shawn oversaw Teva’s small molecule process development group and internal pilot plant manufacturing of clinical supplies. During this time, he generated over 30 publications in peer reviewed journals.

As part of Teva’s focus on biologics, Shawn shifted to large molecule R&D within CMC, with a focus on clinical manufacturing. Initially overseeing continuous improvement efforts in manufacturing, Shawn’s role expanded to oversee Teva’s Biologics Manufacturing Facility for Teva’s novel biologics and biosimiliar clinical programs. In 2021, Shawn became the Vice President of Biologics CMC overseeing Drug Substance, Drug Product and Analytical Development along with Manufacturing and Operations.

Agenda Sessions

  • Building a Framework for Technology Transfer for Late-Phase and Commercial Production